Visualization of inflammation using 19F-magnetic resonance imaging and perfluorocarbons

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 4, Issue 4, 2012, Pages 438-447

  Stoll, Guido ^a   Basse Lüsebrink, Thomas ^a   Weise, Gesa ^a   Jakob, Peter ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC TREATMENT; BACKGROUND SIGNALS; CELL LABELLING; CELL MIGRATION; CEREBRAL ISCHEMIA; CLINICAL MEDICINE; CONTRAST AGENT; DISEASE MODELS; IMAGING HARDWARE; IMAGING SEQUENCE; IMMUNE CELLS; IN-VIVO; INFLAMMATORY RESPONSE; MONOCYTES/MACROPHAGES; MYOCARDIAL INFARCTION; NEUROINFLAMMATION; NOVEL IMAGING TECHNIQUES; ORGAN SYSTEMS; PATHOPHYSIOLOGICAL; PERFLUOROCARBONS; PERIPHERAL NERVES; RECONSTRUCTION TECHNIQUES;

CELLS; CYTOLOGY; FLUORINE; MAGNETIC RESONANCE IMAGING; TISSUE; VISUALIZATION;

PATHOLOGY;

ANTIBIOTIC AGENT; CONTRAST MEDIUM; FLUORINE; FLUOROCARBON; NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ABSCESS; ARTICLE; BRAIN ISCHEMIA; CELL LABELING; CELL MIGRATION; DISEASE MODEL; EMULSION; HEART INFARCTION; HUMAN; IMAGE RECONSTRUCTION; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LIMIT OF DETECTION; MACROPHAGE; MONOCYTE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN DONOR; ORGAN TRANSPLANTATION; PERIPHERAL NERVE INJURY; PHAGOCYTOSIS; PNEUMONIA; PRIORITY JOURNAL; STEM CELL; THROMBOSIS;

FLUORINE; FLUOROCARBONS; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; NERVOUS SYSTEM;

EID: 84862703419     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1168     Document Type: Article

References (55)

1. Muller WA. Mechanisms of leukocyte transendothelial migration. Annu Rev Pathol 2011, 6:323-344.
2. Multiple Sclerosis Therapy Consensus Group (MSTCG), Wiendl H, Toyka KV, Rieckmann P, Gold R, Hartung HP, Hohlfeld R. Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations. J Neurol 2008, 255:1449-1463.
3. Filippi M, Rocca MA. MR imaging of multiple sclerosis. Radiology 2011, 259:659-681.
4. Beckmann N, Cannet C, Babin AL, Blé FX, Zurbruegg S, Kneuer R, Dousset V. In vivo visualization of macrophage infiltration and activity in inflammation using magnetic resonance imaging. WIREs Nanomed Nanobiotechnol 2009, 1:272-298.
5. Stoll G, Bendszus M. Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging. Neuroscience 2009, 158:1151-1160.
6. Stoll G, Bendszus M. New approaches to neuroimaging of central nervous system inflammation. Curr Opin Neurol 2010, 23:282-286.
7. Jander S, Schroeter M, Saleh A. Imaging inflammation in acute brain ischemia. Stroke 2007, 38(suppl 2):642-645.
8. Tourdias T, Roggerone S, Filippi M, Kanagaki M, Rovaris M, Miller DH, Petry KG, Brochet B, Pruvo JP, Radue EW, et al. Assessment of disease activity in multiple sclerosis phenotypes using combined gadolinium and iron oxide nanoparticles MR contrast. Radiology. In press.
9. Farr TD, Seehafer JU, Nelles M, Hoehn M. Challenges towards MR imaging of the peripheral inflammatory response in the subacute and chronic stages of transient focal ischemia. NMR BioMed 2011, 24:35-45.
10. Ahrens ET, Flores R, Xu H, Morel PA. In vivo imaging platform for tracking immunotherapeutic cells. Nat Biotechnol 2005, 23:983-987.
11. Nöth U, Morrissey SP, Deichmann R, Jung S, Adolf H, Haase A, Lutz J. Perfluoro-15-crown-5-ether labelled macrophages in adoptive transfer experimental allergic encephalomyelitis. Artif Cells Blood Substit Immobil Biotechnol. 1997, 25:243-254.
12. Holland GN, Bottomley PA, Hinshaw WS. 19F magnetic resonance imaging. J Magn Res 1977, 28: 133-136.
13. Janjic JM, Ahrens ET. Fluorine-containing nanoemulsions for MRI cell tracking. WIREs Nanomed Nanobiotechnol 2009, 1:492-501.
14. Clark LC Jr, Gollan F.Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science 1966, 152:1755-1756.
15. Riess JG. Perfluorocarbon-based oxygen delivery. Artif Cells Blood Substit Immobil Biotechnol 2006, 34:567-580.
16. Srinivas M, Cruz LJ, Bonetto F, Heerschap A, Figdor CG, de Vries IJM. Customizable, multifunctional fluorocarbon nanoparticles for quantitative in vivo imaging using 19F MRI and optical imaging. Biomaterials 2010, 31:7070-7077.
17. Mason RP, Antich PP, Babcock EE, Gerberich JL, Nunally RL. Perfuorocarbon imaging in vivo: A 19F MRI study in tumor-bearing mice. Magn Reson Imag 1989, 7:475-485.
18. Leese PT, Noveck RJ, Shorr JS, Woods CM, Flaim KE, Keipert PE. Randomized safety studies of intravenous perflubron emulsion. I. Effects on coagulation function in healthy volunteers. Anesth Analg 2000, 91:804-811.
19. Srinivas M, Heerschap A, Ahrens ET, Figdor CG, de Vries IJ. (19)F MRI for quantitative in vivo cell tracking. Trends Biotechnol 2010, 28:363-370.
20. Bulte JW. Hot spot MRI emerges from the background. Nat Biotechnol 2005, 23:945-946.
21. Bonetto F, Srinivas M, Heerschap A, Mailliard R, Ahrens ET, Figdor CG, de Vries IJ. A novel (19)F agent for detection and quantification of human dendritic cells using magnetic resonance imaging. Int J Cancer 2011, 129:365-373. doi:10.1002/ijc.25672.
22. Srinivas M, Turner MS, Janjic JM, Morel PA, Laidlaw DH, Ahrens ET. In vivo cytometry of antigen-specific t cells using 19F MRI. Magn Reson Med 2009, 62:747-753.
23. Flögel U, Ding Z, Hardung H, Jander S, Reichmann G, Jacoby C, Schubert R, Schrader J. In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging. Circulation 2008, 118:140-148.
24. Ebner B, Behm P, Jacoby C, Burghoff S, French BA, Schrader J, Flögel U. Early assessment of pulmonary inflammation by 19F MRI in vivo. Circ Cardiovasc Imaging 2010 3:202-210.
25. Flögel U, Su S, Kreideweiss I, Ding Z, Galbarz L, Fu J, Jacoby C, Witzke O, Schrader J. Noninvasive detection of graft rejection by in vivo 19F MRI in the early stage. Am J Transplant 2011, 11:235-244. doi: 10.1111/j.1600-6143.2010.03372.
26. Hitchens TK, Ye Q, Eytan DF, Janjic JM, Ahrens ET, Ho C. 19F MRI detection of acute allograft rejection with in vivo perfluorocarbon labeling of immune cells. Magn Reson Med 2011, 65:1144-1153. doi: 10.1002/mrm.22702.
27. 19F magnetic resonance imaging (MRI). PLoS One 2011, 6:e18246
28. Stoll G, Bendszus M, Perez J, Pham M. Magnetic resonance imaging of the peripheral nervous system. J Neurol 2009, 256:1043-1051.
29. Vellinga MM, Oude Engberink RD, Seewann A, Pouwels PJ, Wattjes MP, van der Pol SM, Pering C, Polman CH, de Vries HE, Geurts JJ, Barkhof F. Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. Brain 2008, 131(Pt 3):800-807.
30. Ladewig G, Jestaedt L, Misselwitz B, Solymosi L, Toyka K, Bendszus M, Stoll G. Spatial diversity of blood-brain barrier alteration and macrophage invasion in experimental autoimmune encephalomyelitis: a comparative MRI study. Exp Neurol 2009, 220:207-211.
31. Weise G, Basse-Luesebrink TC, Wessig C, Jakob PM, Stoll G. In vivo imaging of inflammation in the peripheral nervous system by (19)F MRI. Exp Neurol 2011, 229:494-501.
32. Castro O, Nesbitt AE, Lyles D.Effect of a perfluorocarbon emulsion (Fluosol-DA) on reticuloendothelial system clearance function. Am J Hematol 1984, 16:15-21.
33. Ahrens ET, Young WB, Xu H, Pusateri LK. Rapid quantification of inflammation in tissue samples using perfluorocarbon emulsion and fluorine-19 nuclear magnetic resonance. Biotechniques 2011, 50:229-234.
34. Stoll G, Jander S, Schroeter M. Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol 1998, 56:149-171.
35. Schroeter M, Jander S, Stoll G. Non-invasive induction of focal cerebral ischemia in mice by photothrombosis of cortical microvessels: characterization of inflammatory responses. J Neurosci Methods 2002, 117:43-49.
36. Schroeter M, Jander S, Huitinga I, Witte OW, Stoll G. Phagocytic response in photochemically induced infarction of rat cerebral cortex. The role of resident microglia. Stroke 1997, 28:382-386.
37. 19F MRI. PLoS One 2011, 6:e28143. doi:10.1371/journal.pone.0028143. (Epub ahead of print; December 15, 2011.)
38. Stoll G, Kleinschnitz C, Meuth SG, Braeuninger S, Ip CW, Wessig C, Nölte I, Bendszus M. Transient widespread blood-brain barrier alterations after cerebral photothrombosis by gadofluorine M-enhanced magnetic resonance imaging. J Cereb Blood Flow Metab 2009, 29:331-341.
39. Fan X, River JN, Muresan AS, Popescu C, Zamora M, Culp RM, Karczmar GS. MRI of perfluorocarbon emulsion kinetics in rodent mammary tumours. Phys Med Biol 2006, 51:211-220.
40. 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. FASEB J 2007, 21:1647-1654.
41. 19F: a versatile reporter for non-invasive physiology and pharmacology using magnetic resonance. Curr Med Chem 2005, 12:819-848.
42. Srinivas M, Morel PA, Ernst LA, Laidlaw DH, Ahrens ET. Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model. Magn Reson Med 2007, 58:725-734.
43. Ruiz-Cabello J, Barnett BP, Bottomley PA, Bulte JW. Fluorine (19F) MRS and MRI in biomedicine. NMR Biomed 2011, 24:114-1129.
44. 19F magnetic resonance imaging of perfluorooctylbromide. Magn Reson Med 2010, 63:1119-1124.
45. Waiczies H, Lepore S, Janitzek N, Hagen U, Seifert F, Ittermann B, Purfürst B, Pezzutto A, Paul F, Niendorf T, et al. Perfluorocarbon particle size influences magnetic resonance signal and immunological properties of dendritic cells. PLoS One 2011, 6:e21981.
46. Ruiz-Cabello J, Walczak P, Kedziorek DA, Chacko VP, Schmieder AH, Wickline SA, Lanza GM, Bulte JW. In vivo "hot spot" MR imaging of neural stem cells using fluorinated nanoparticles. Magn Reson Med 2008, 60:1506-1511.
47. 19F imaging agents. Magn Reson Med 2011, 66:1116-1122.
48. 19F CSI. J Magn Reson 2010, 207:262-273.
49. Chen J, Lanza GM, Wickline SA. Quantitative magnetic resonance fluorine imaging: today and tomorrow. WIREs Nanomed Nanobiotechnol 2010, 2:431-440.
50. 19F imaging using inductively coupled reference signal injection. Magn Reson Med 2010, 63:570-573.
51. 19F magnetic resonance imaging. PLoS One 2011, 6:e29040. doi:10.1371/journal.pone.0029040. (Epub ahead of print; December 28, 2011.)
52. 1 mapping. Magn Reson Med 2011, 65:1125-1130.
53. Sacolick LI, Wiesinger F, Hancu I, Vogel MW. B1 mapping by Bloch-Siegert Shift. Magn Reson Med 2010, 63:1315-1322.
54. Basse-Lüsebrink TC, Sturm VJF, Kampf T, Stoll G, Jakob PM. Fast CPMG-based Bloch-Siegert $B_{1}^{+}$ mapping. Magn Reson Med 2011, 67:405-418.
55. Sturm VJF, Basse-Lüsebrink TC, Kampf T, Stoll G, Jakob PM. Improved encoding strategy for CPMG-based Bloch-Siegert $B_{1}^{+}$ mapping. Magn Reson Med 2011, doi:10.1002/mrm.23232. (Epub ahead of print; December 21, 2011.)